INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 December 2012
Total net assets |
£127.0m |
NAV per share |
229.0p |
Share price |
200.0p |
Total value of unquoted investments |
£20.2m |
Total number of portfolio companies |
66 |
Cash |
1% NAV |
Cash committed and reserved to unquoted investments |
(5)% NAV |
Portfolio companies with < 1 year of cash |
16.96% NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen Celgene Gilead |
7.6 7.3 4.5 |
Aptiv |
4.4 |
Onyx |
3.8 |
Alexion |
3.6 |
Pharmaxis |
3.3 |
Biogen |
3.2 |
YM Biosciences Insulet |
3.1 2.8 |
|
----------- |
Total |
43.6 |
Geographical Allocation |
% |
United States & Canada |
86 |
Europe |
10 |
Australia |
3 |
Cash |
1 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
83 |
Unquoted |
16 |
Cash |
1 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
17 JANUARY 2013